期刊
VIRUSES-BASEL
卷 15, 期 7, 页码 -出版社
MDPI
DOI: 10.3390/v15071510
关键词
virus-specific T-cells; T-cell transfer; immune therapy; cellular therapy; viral infections; central nervous system; progressive multifocal leukoencephalopathy; cytomegalovirus; adenovirus; encephalitis; multiple sclerosis
类别
Opportunistic viral infections of the central nervous system are a significant cause of morbidity and mortality among immunocompromised patients. Antiviral treatments are usually ineffective, so the prognosis depends on timely immune reconstitution. Virus-specific T-cells are increasingly being recognized as a valuable tool to treat these infections, and have potential applications in the treatment of progressive multiple sclerosis and EBV-associated central nervous system inflammatory disease. The key future milestones of this treatment strategy are also discussed.
Opportunistic viral infections of the central nervous system represent a significant cause of morbidity and mortality among an increasing number of immunocompromised patients. Since antiviral treatments are usually poorly effective, the prognosis generally relies on the ability to achieve timely immune reconstitution. Hence, strategies aimed at reinvigorating antiviral immune activity have recently emerged. Among these, virus-specific T-cells are increasingly perceived as a principled and valuable tool to treat opportunistic viral infections. Here we briefly discuss how to develop and select virus-specific T-cells, then review their main indications in central nervous system infections, including progressive multifocal leukoencephalopathy, CMV infection, and adenovirus infection. We also discuss their potential interest in the treatment of progressive multiple sclerosis, or EBV-associated central nervous system inflammatory disease. We finish with the key future milestones of this promising treatment strategy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据